Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.

Ryota ShibakiDaichi FujimotoTsukasa NozawaAkira SanoYuka KitamuraJunya FukuokaYuki SatoTakashi KijimaHirotaka MatsumotoToshihide YokoyamaSatoru MiuraAkito HataMotohiro TamiyaYoshihiko TaniguchiJun SugisakaNaoki FuruyaHisashi TanakaNobuyuki YamamotoYasuhiro KohHiroaki Akamatsu

Published in: Journal for immunotherapy of cancer (2024)

The spatial analysis of the TIME using machine learning predicted the immunotherapy efficacy in patients with SCLC, thus supporting its role as an immunotherapy biomarker.

Keyphrases

free survival
small cell lung cancer
machine learning
deep learning
convolutional neural network
artificial intelligence